The antibody aducanumab reduces Aβ plaques in Alzheimer's disease | Nature
Biogen is ready to roll on lecanemab production, CFO says
Aduhelm (aducanumab) Q+A - Penn Memory Center
Aduhelm (aducanumab) Q+A - Penn Memory Center
The Future of Alzheimer's Treatment? Approval of Aduhelm & Other Anti-Amyloid Antibodies – Montgomery County Medical Society
Congressional Probe of Alzheimer's Drug Approval Finds Fault With FDA Actions | MedPage Today
Biogen's Aducanumab: A Look at the Drug's History and Recent Updates | BioSpace
FDA changes prescribing instructions to limit use of contentious Alzheimer's drug amid public backlash | KTLA
Biogen readies Alzheimer's hopeful aducanumab for U.S. launch as stateside sales plummet | Fierce Pharma
Biogen stuns with planned US FDA filing for previously scrapped Alzheimer's drug | S&P Global Market Intelligence
Controversial FDA Approval Of Alzheimer's Drug Aducanumab Sets Stage For Possible Medicare Coverage Battle
Congressional Investigation into Alzheimer's Drug Aduhelm Faults the F.D.A. and Biogen - The New York Times
James Deardorff on X: ""Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease" - Hmm... 1. https://t.co/k7Ga4ja0br 2. https://t.co/5cr8gYW72s https://t.co/7NboyUVjWr" / X
Biogen's Alzheimer's Drug Gets FDA Approval, Mixed Reviews | The Scientist Magazine®
Early Access Programs | Biogen
Aduhelm safety: the data gap on aducanumab's brain swelling side effect
Biogen gives up seeking European approval for aducanumab - Drug Discovery and Development
EISAI PRESENTED NEW ANALYSES OF ARIA AND QOL ON LECANEMAB IN CLARITY AD AT THE AD/PD™ 2023 ANNUAL MEETING
June 7, 2021: A Historic Day | The Long and Winding Road...
FDA approves much-debated Alzheimer's drug panned by experts | AP News
U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big day" for patients | Reuters
Biogen releases long-term Aduhelm data
The Science of Aging: Summer 2020 – The Science of Aging
EMA gives thumbs down to Biogen's Alzheimer's drug aducanumab - Drug Discovery and Development
